MTHFS
protein-codingmethenyltetrahydrofolate synthetase
Gene summary
The protein encoded by this gene is an enzyme that catalyzes the conversion of 5-formyltetrahydrofolate to 5,10-methenyltetrahydrofolate, a precursor of reduced folates involved in 1-carbon metabolism. An increased activity of the encoded protein can result in an increased folate turnover rate and folate depletion. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jun 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~63.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032705
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032705
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic
Intervention: Neurologic
Rationale: Individuals have been described with refractory seizures and recurrent episodes of hyperthermia, which responded to lamotrigine; A combination of oral L-5-methyltetrahydrofolate and intramuscular methylcobalamin has been described as resulting in mild functional improvements
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MTHFS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006441.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 8 | 1 | 10 | ||
| missense | 1 | 2 | 26 | 4 | 3 | 36 |
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 4 | 4 | 28 | 12 | 4 | 52 |
Highest pathogenic variant AF is 0.0001400227
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006432.1 | 3 | MANE Select | |
| Ensembl | ENSP00000258874.4 | 3 | MANE Select | |
| RefSeq | NP_001186687.1 | 2 | Standard | |
| Ensembl | ENSP00000489076.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Antimetabolite Pathway - Folate Cycle, Pharmacodynamics
- One carbon pool by folate - Homo sapiens (human)
- Methotrexate Pathway (Cancer Cell), Pharmacodynamics
- Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics
- Folate malabsorption, hereditary
Biological Process
- glutamate metabolic process
- folic acid-containing compound biosynthetic process
- formate metabolic process
- tetrahydrofolate interconversion
- tetrahydrofolate metabolic process
Molecular Function
- ATP binding
- folic acid binding
- 5-formyltetrahydrofolate cyclo-ligase activity
- metal ion binding
Cellular Component
- cytoplasm
- mitochondrion
- mitochondrial matrix
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000258874
- Coding exons
- 3
- Length
- 63795
- Individuals with no LoFs
- 125721
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 27
- Defined
- 125748
- p
- 0.000107
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.553 | 97 | 114 | 0.854 | 0.00000598 | 1323 |
| Missense (PolyPhen) | 37 | 45.36 | 0.8157 | 526 | ||
| Synonymous | -0.436 | 47 | 43.3 | 1.08 | 0.00000230 | 389 |
| Loss of Function | 0.504 | 6 | 7.49 | 0.801 | 5.01e-7 | 79 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00014 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Contributes to tetrahydrofolate metabolism. Helps regulate carbon flow through the folate-dependent one-carbon metabolic network that supplies carbon for the biosynthesis of purines, thymidine and amino acids. Catalyzes the irreversible conversion of 5-formyltetrahydrofolate (5-FTHF) to yield 5,10- methenyltetrahydrofolate. {ECO:0000269|PubMed:8522195}.;
Recessive Scores
- pRec
- 0.229
Intolerance Scores
- LoFtool
- 0.547
- RVIS EVS
- 0.04
- RVIS percentile EVS
- 56.64
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.991
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |